Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence
Baron-Papillon
President (Sanofi)
To Be
Confirmed
Vice-President
Andreas
Potthoff
(Abbott)
Hugo
Gomes da Silva
(AstraZeneca)
Sharon
McHale
(CSL Seqirus)
Sue
Middleton
(GSK)
Jürgen
Betzing
(IDT Biologika)
Jurgen
Kwik
(Janssen/JnJ)
John
Lepore
(Moderna)
Nicoletta
Luppi
(MSD)
Kelly
Cappio
(Novavax)
Marc
Dreiner
Treasurer (Pfizer)
Logan
Rae
(Takeda)
Juan Carlos
Jamarillo
(Valneva)

Executive office

Sibilia
Quilici
Executive Director
Laurent
Louette
Director Public Affairs & Country Liaison
Anna
Czwarno
Director, Regulatory and R&D
Anna
Vicere
Senior Manager, Access Policy & Public Affairs
Polina
Zoteva
Communications Lead
Anne
Meynaerts
Administrative Assistant

Working Group Chairs